El índice h5 es el índice h de los artículos publicados en los últimos 5 años completos. Se trata del número mayor h en cuanto a que h artículos publicados entre 2014 - 2018 deben tener al menos h citas cada uno.ocultar
La mediana h5 de una publicación es el número mediano de citas de los artículos que componen el índice h5.ocultar
Título / AutorCitado porAño
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
T Bailey, BW Bode, MP Christiansen, LJ Klaff, S Alva
Diabetes Technology & Therapeutics 17 (11), 787-794
2822015
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
D Rodbard
Diabetes Technology & Therapeutics 18 (S2), S2-3-S2-13
2382016
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
SK Garg, SA Weinzimer, WV Tamborlane, BA Buckingham, BW Bode, ...
Diabetes Technology & Therapeutics 19 (3), 155-163
1832017
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
BP Kovatchev, SD Patek, EA Ortiz, MD Breton
Diabetes Technology & Therapeutics 17 (3), 177-186
992015
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes
D Rodbard
Diabetes Technology & Therapeutics 19 (S3), S-25-S-37
952017
Adding Heart Rate Signal to a Control-to-Range Artificial Pancreas System Improves the Protection Against Hypoglycemia During Exercise in Type 1 Diabetes
MD Breton, SA Brown, CH Karvetski, L Kollar, KA Topchyan, ...
Diabetes Technology & Therapeutics 16 (8), 506-511
832014
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management
P Choudhary, BS Olsen, I Conget, JB Welsh, L Vorrink, JJ Shin
Diabetes Technology & Therapeutics 18 (5), 288-291
832016
Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects
J Kropff, JH DeVries
Diabetes Technology & Therapeutics 18 (S2), S2-53-S2-63
812016
Association of Neutrophil-Lymphocyte Ratio with Glucose Intolerance: An Indicator of Systemic Inflammation in Patients with Type 2 Diabetes
A Shiny, YS Bibin, CS Shanthirani, BS Regin, RM Anjana, ...
Diabetes Technology & Therapeutics 16 (8), 524-530
802014
The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During Exercise
T Danne, C Tsioli, O Kordonouri, S Blaesig, K Remus, A Roy, B Keenan, ...
Diabetes Technology & Therapeutics 16 (6), 338-347
792014
A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes
V Matuleviciene, JI Joseph, M Andelin, IB Hirsch, S Attvall, A Pivodic, ...
Diabetes Technology & Therapeutics 16 (11), 759-767
732014
Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin
S Mudaliar, RR Henry, G Boden, S Smith, AG Chalamandaris, ...
Diabetes Technology & Therapeutics 16 (3), 137-144
732014
A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
RH Jani, V Pai, P Jha, G Jariwala, S Mukhopadhyay, A Bhansali, S Joshi
Diabetes Technology & Therapeutics 16 (2), 63-71
722014
Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 Hours
AC van Bon, YM Luijf, R Koebrugge, R Koops, JBL Hoekstra, JH DeVries
Diabetes Technology & Therapeutics 16 (3), 131-136
712014
Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor
TS Bailey, A Ahmann, R Brazg, M Christiansen, S Garg, E Watkins, ...
Diabetes Technology & Therapeutics 16 (5), 277-283
692014
Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
G Freckmann, A Baumstark, C Schmid, S Pleus, M Link, C Haug
Diabetes Technology & Therapeutics 16 (2), 113-122
682014
A Systematic Review of Electronic Portal Usage Among Patients with Diabetes
DJ Amante, TP Hogan, SL Pagoto, TM English
Diabetes Technology & Therapeutics 16 (11), 784-793
652014
Improved Metabolic Control in Pediatric Patients with Type 1 Diabetes: A Nationwide Prospective 12-Year Time Trends Analysis
K Dovc, SS Telic, L Lusa, N Bratanic, M Zerjav-Tansek, P Kotnik, ...
Diabetes Technology & Therapeutics 16 (1), 33-40
642014
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery
B Kovatchev, P Cheng, SM Anderson, JE Pinsker, F Boscari, ...
Diabetes Technology & Therapeutics 19 (1), 18-24
642017
Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey
JC Pickup, N Yemane, A Brackenridge, S Pender
Diabetes Technology & Therapeutics 16 (3), 145-149
622014
1 - 20
Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.